Enable job alerts via email!
A leading UK healthcare trust in Coventry is seeking an experienced ophthalmologist for a permanent role. The position offers significant clinical, laser, and surgical exposure, with responsibilities including outpatient clinics, emergency duties, and independent theatre sessions. Ideal candidates should be self-motivated and confident in delivering ophthalmology services. This role provides opportunities for professional development and is a crucial part of patient care.
Interview 31st October 2025. This post offers significant clinical, laser and surgical exposure with opportunity to develop subspecialty experience. The post is suitable for those seeking to gain CESR and varied subspecialty experience. The post offers independent surgical, laser and clinical sessions. The post is for a permanent contract.
The post is offered with a job plan of 10 Professional Activities (PAs). On-call duties (1:8-1:9) are offered based on relevant experience and departmental need.
Informal enquiries should be made to Mr N.P. Manjunatha (medical staffing lead) on 02476966498 or Professor Harpreet Ahluwalia, Clinical Lead for Ophthalmology on 02476 966506.
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, rated as good by the Care Quality Commission, is one of the largest teaching Trusts in the UK. We are extremely proud of our skilled employees across our hospital sites in Coventry and Rugby, with high quality patient care positioned at the heart of everything we do. Boasting some of the most modern facilities in Western Europe, the Trust is renowned for being at the forefront of research and innovation as part of its blossoming reputation as a national and international leader in healthcare. By joining our exciting journey, you will form part of a passionate, talented team and will be able to access a wide range of learning and development opportunities. There has never been a better time to join our team.
The person for this role will be able to:
This advert closes on Thursday 9 Oct 2025.